Overview

The Office of Technology Development (OTD) supports NIAID's intramural and extramural research programs by facilitating collaborations between NIAID researchers and external research and development organizations. OTD's staff utilizes scientific, legal and business expertise to negotiate agreements with universities, small biotechnology companies, large national and multinational pharmaceutical concerns, and other government agencies.

OTD manages NIAID's portfolio of patents and inventions and serves as NIAID's resource for all issues concerning intellectual property. OTD facilitates receipt of CRADA funds, supports NIH's licensing program, and tracks license royalty receipts. OTD provides NIAID investigators with training on NIH technology transfer policies and regulations. OTD coordinates NIAID's interactions with NIH's other Institutes and Centers on technology transfer issues, is an active participant in many committees that develop and implement NIH technology transfer policy, and serves as a resource accessible to all NIH staff.